SET and non-small cell lung carcinoma: Moreover, we found that ectopic expression of SET induces resistance in NSCLC cells to paclitaxel, and, importantly, antagonizing SET via siRNA or a novel SET inhibitor, EMQA, significantly enhances the in vitro and in vivo anti-tumor effects of paclitaxel.